No increased prevalence of adrenocortical insufficiency in human immunodeficiency virus-associated tuberculosis

被引:9
|
作者
Hawken, MP
Ojoo, JCO
Morris, JS
Kariuki, EW
Githui, WA
Juma, ES
Gathua, SN
Kimari, JN
Thiongo, LN
Raynes, JG
Broadbent, P
Gilks, CF
Otieno, LS
McAdam, KPWJ
机构
[1] UNIV LONDON LONDON SCH HYG & TROP MED,DEPT EPIDEMIOL & POPULAT SCI,LONDON WC1E 7HT,ENGLAND
[2] KENYA GOVT MED RES CTR,CLIN RES CTR,NAIROBI,KENYA
[3] KENYATTA NATL HOSP,DEPT MED,NAIROBI,KENYA
来源
TUBERCLE AND LUNG DISEASE | 1996年 / 77卷 / 05期
关键词
D O I
10.1016/S0962-8479(96)90118-5
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Setting: Acute medical wards, Kenyatta National Hospital, Nairobi, Kenya, Objective: To determine the prevalence of adrenocortical insufficiency in human inmunodeficiency virus (HIV)-1 infected and non-infected patients with tuberculosis, Design: One hundred and seventy-four patients with proven tuberculosis (90 HIV-1 positive and 84 HIV-1 negative) were assessed for adrenocortical insufficiency with a 30 min synacthen stimulation test, Results: Fifty-one percent of those with pulmonary tuberculosis and 56% of those with extra-pulmonary tuberculosis had a subnormal cortisol response. However there was no statistically significant difference between the HIV-1 infected and non-infected patients in either group, Conclusion: While an impaired cortisol response is common in tuberculosis, it is no more prevalent in HIV-1 infected patients than non-infected patients with tuberculosis.
引用
收藏
页码:444 / 448
页数:5
相关论文
共 50 条
  • [1] Human Immunodeficiency Virus-Associated Tuberculosis
    Wilkinson, Katalin A.
    Schwander, Stephan
    Torok, M. Estee
    Meintjes, Graeme
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2011,
  • [2] Managing Human Immunodeficiency Virus-associated Tuberculosis in the Dolutegravir Era
    Maartens, Gary
    Meintjes, Graeme
    CLINICAL INFECTIOUS DISEASES, 2020, 70 (04) : 557 - 558
  • [3] EVOLUTION OF RIFAMPIN RESISTANCE IN HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED TUBERCULOSIS
    NOLAN, CM
    WILLIAMS, DL
    CAVE, MD
    EISENACH, KD
    ELHAJJ, H
    HOOTON, TM
    THOMPSON, RL
    GOLDBERG, SV
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 1995, 152 (03) : 1067 - 1071
  • [4] Human Immunodeficiency Virus-Associated Tuberculosis Update on Prevention and Treatment
    Dierberg, Kerry L.
    Chaisson, Richard E.
    CLINICS IN CHEST MEDICINE, 2013, 34 (02) : 217 - +
  • [5] Changing prevalence of human immunodeficiency virus-associated oral lesions
    Dios, PD
    Ocampo, A
    Miralles, C
    Limeres, J
    Tomás, I
    ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY AND ENDODONTICS, 2000, 90 (04): : 403 - 404
  • [6] Advances in Antiretroviral Therapy for Patients with Human Immunodeficiency Virus-Associated Tuberculosis
    Le, Xiaoqin
    Shen, Yinzhong
    VIRUSES-BASEL, 2024, 16 (04):
  • [7] HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED GLOMERULOSCLEROSIS
    HUMPHREYS, MH
    KIDNEY INTERNATIONAL, 1995, 48 (02) : 311 - 320
  • [8] HUMAN IMMUNODEFICIENCY VIRUS-ASSOCIATED PSYCHOSIS
    KESSING, LV
    NORDIC JOURNAL OF PSYCHIATRY, 1994, 48 (01) : 57 - 61
  • [9] Human immunodeficiency virus-associated lymphomas
    Straus, DJ
    MEDICAL CLINICS OF NORTH AMERICA, 1997, 81 (02) : 495 - &
  • [10] Human immunodeficiency virus-associated malignancies
    Myskowski, PL
    DERMATOLOGY AT THE MILLENNIUM, 1999, : 293 - 296